Skip to content
BigOmics Analytics
Menu
  • About
    • Team & Board
    • Investors
  • Platforms
    • Omics Playground
    • Rep-seq Playground (beta)
    • Multi-Omics Playground (beta)
  • Benefits
  • Pricing
  • Resources
    • Blog
    • Events
    • Tutorials
    • Community forum
    • Press release
  • Jobs
  • Contact

Category: Case study

Case study

Profilin 1 and its role in proteasome inhibitors resistance

Browsing through the most recent proteomics dataset on the public PRIDE database, I came across this study (PXD033148) from Wang and colleagues  at Xiangya Hospital of Central South University in …

Case study

The Role of Osteopontin on Prostatic Fibrosis and Inflammation

For this post, I will re-analyse the transcriptomic data from a recently published article on the role of osteopontin on prostatic fibrosis and inflammation (Popovics et al, 2021). Fibrosis occurs …

Case study

The role of the microbiome on social interactions in mice

The original article by Stilling et al (2018), described the association between gut microbiome composition and social behaviour in mice. They compared the social interaction of germ-free mice (GF, devoid …

Aging Insights from the GTEx Tissue Collection
Case study

Insights into Aging from the GTEx Tissue Collection using Omics Playground

The Genotype-Tissue Expression program (GTEx) is an extensive collection of gene expression profiles from 54 different tissue sites across more than 1000 individuals. This data can provide various insights on …

Case study

IL-17A as a possible therapeutic target for Osteoarthritis

For this brief article, I have decided to re-analyse the RNA-seq data from a recently published paper on the osteoarthritis-like (OA-like) transcription changes induced in response to Interleukin-17 (IL-17) (Mimpen …

Case study

Glucocorticoid Resistance in Multiple Myeloma: a Dataset Re-analysis

For this post, I decided to re-analyse a dataset from a recent article by Logie et al (2021) using our Omics Playground platform. Multiple Myeloma (MM) is a malignancy that …

Case study / Tutorial

Part I: Re-analysis of the first public SARS-CoV-2 transcriptomics data from Blanco-Melo et. al.

Do you work with COVID-19 related transcriptomic data? Then re-analyse the first public transcriptomic data from Blanco-Melo lab at covid19.bigomics.ch on your own in a few minutes The first public …

Case study / Tutorial

Finding Potential Biomarkers And Therapeutic Drugs With Coronavirus Datasets (Part 2)

In a previous post, Axel Martinelli analysed an in vitro infection with a Middle Eastern coronavirus using our special edition of the Omics Playground platform. In that analysis he identified the SSX2 gene as a potential …

Case study / Tutorial

Finding Potential Biomarkers And Therapeutic Drugs With Coronavirus Datasets (Part 1)

Our company, Bigomics Analytics, recently launched the Viromics Playground, an open access online version of the Omics Playground platform that includes over 200 viral infection transcriptomes. I thought it might …

Join our Newsletter

* indicates required

You can unsubscribe at any time by clicking the link in the footer of our emails. For more information please read our Privacy Policy and Terms and Conditions

bigomicsFollow

Skip the queue. Do-it-yourself with world's first self-service analytics platform for Big Omics data. Try Omics Playground now at https://t.co/0zzvGiUVIc.

bigomics
bigomicsbigomics@bigomics·
13 May

Check out this podcast episode from @TheStrugglingS4 featuring our co-founders Ivo Kwee and Murodzhon Akhmedov sharing their stories and talking about the origins of BigOmics! 🚀

The Struggling Scientists Podcast@TheStrugglingS4

📢New ep 😁!
We talked with the CEO & CTO of BigOmics about their journey toward their startup

Link:
🔗http://spoti.fi/3F7wWjf

@PhDVoice @gradconfessing @AcademicChatter #AcademicTwitter @OpenAcademics #scicomm @PhD_Genie @ThePhDPlace @thephdbreakdown @MasterAcademia_

Reply on Twitter 1525094855151583233Retweet on Twitter 15250948551515832332Like on Twitter 15250948551515832333Twitter 1525094855151583233
bigomicsbigomics@bigomics·
9 May

Thank you to everyone who stopped by our booth at Bio-IT World 2022! It was great meeting you in person. Please let us know if you liked our t-shirts and swags. If you're not in the picture, feel free to share yours in the comments!

Stay tuned for our next events 🚀

#BioIT22

Reply on Twitter 1523693021614665733Retweet on Twitter 1523693021614665733Like on Twitter 15236930216146657331Twitter 1523693021614665733
Load More...

Recent Posts

  • Profilin 1 and its role in proteasome inhibitors resistance
  • BigOmics closes Pre-Series A with additional investment from Eppendorf
  • The Role of Osteopontin on Prostatic Fibrosis and Inflammation
  • BigOmics to assist Remix Therapeutics with omics data analysis in their mission to reprogram RNA processing
  • BigOmics Raises $1.85M to Revolutionize Omics Data Analytics

Categories

  • Case study
  • Editorial
  • Events
  • In the news
  • Jobs
  • Press release
  • Research paper
  • Tutorial

Navigation

  • Home
  • Blog
  • Login
  • Pricing
  • Tutorials

Links

Omics Playground

Where to find us

BigOmics Analytics SA
c/o USI Startup Centre
Via La Santa 1, 6962 Viganello
Switzerland

info@bigomics.ch

Legal

Impressum
Privacy policy
Terms and conditions
Service level agreement
Change your Cookie Consent
Follow us
Copyright © 2022 BigOmics Analytics OnePress theme by FameThemes